Gamida Cell Ltd.

0.38 USD
-0.00 (-0.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Gamida Cell Ltd. stock is up 9.3% since 30 days ago. The next earnings date is Mar 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
29 Jan 15:13 16 Jan, 2026 0.50 CALL 1000 1430
29 Jan 15:15 16 Jan, 2026 0.50 CALL 1000 1430

About Gamida Cell Ltd.

Gamida Cell Ltd. develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk malignancies, as well as in Phase I/II clinical trials.